Skip to main content

Zunveyl Dosage

Generic name: benzgalantamine 5mg
Dosage form: tablet, delayed release
Drug class: Cholinesterase inhibitors

Medically reviewed by Drugs.com. Last updated on Feb 18, 2025.

Recommended Dosage and Administration

Dosage

The recommended starting dosage is 5 mg twice a day (10 mg/day) by mouth. Increase to initial maintenance dosage of 10 mg twice daily (20 mg/day) after a minimum of 4 weeks, based on clinical response and tolerability. Dosage may be increased to the maximum recommended dosage of 15 mg twice a day (30 mg/day) after a minimum of 4 weeks at 10 mg twice daily.

Administration

ZUNVEYL can be taken with or without food.

ZUNVEYL should not be taken with alcohol.

Swallow whole; do not split, crush or chew.

Ensure adequate fluid intake during treatment.

Interruption of Therapy

If therapy has been interrupted for more than three days, the patient should be restarted at the lowest dosage and the dosage escalated to the current dose.

Recommended Dosage in Patients with Hepatic Impairment

No dosage adjustment is recommended for patients with mild hepatic impairment (Child-Pugh score of 5-6). In patients with moderate hepatic impairment (Child-Pugh score of 7-9), the dosage should generally not exceed 10 mg twice daily (20 mg/day). The use of ZUNVEYL in patients with severe hepatic impairment (Child-Pugh score of 10-15) is not recommended.

Recommended Dosage in Patients with Renal Impairment

In patients with creatinine clearance of 9 to 59 mL/min, the dosage should generally not exceed 10 mg twice daily (20 mg/day). In patients with creatinine clearance less than 9 mL/min, the use of ZUNVEYL is not recommended.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer